Yan Xia

Statistics

Publications

Citations

150

H-Index

Active since

2023

Affiliations

Fudan University Shanghai Cancer Center(Current)

Yan Xia is an author at Fudan University Shanghai Cancer Center specializing in ai adoption intention, breast cancer pharmacotherapy, and triple-negative breast cancer immunotherapy.

ORCID

Publications per year

2023–2024

Publications

Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial

Lei Fan, Zhonghua Wang, Linxiaoxi Ma et al. · The Lancet Oncology · 2024 · 64 citations

Medicine, Oncology, Breast Oncology +8

Driving Factors of Generative AI Adoption in New Product Development Teams from a UTAUT Perspective

Yan Xia, Yue Chen · International Journal of Human-Computer Interaction · 2024 · 45 citations

Management, Organizational Behavior, Artificial Intelligence +12

AAV-mediated hepatic LPL expression ameliorates severe hypertriglyceridemia and acute pancreatitis in Gpihbp1 deficient mice and rats

Chenchen Yuan, Xu Yao, Guotao Lu et al. · Molecular Therapy · 2023 · 15 citations · Full text

Life Sciences, Biochemistry, Molecular Medicine +17

Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial

Min He, Yizhou Jiang, Yue Gong et al. · BMJ · 2024 · 15 citations · Full text

Medicine, Oncology, Breast Oncology +11

Telomere dysfunction alters intestinal stem cell dynamics to promote cancer

Kyle A. LaBella, Wen-Hao Hsu, Jiexi Li et al. · Developmental Cell · 2024 · 11 citations · Full text

Life Sciences, Cancer Biology, Cell Biology +10

1–5 of 5